Pub-2025

Articles

Title
Single-cell RNA sequencing defines distinct disease subtypes and reveals hyporesponsiveness to interferon in asymptomatic Waldenstrom’s Macroglobulinemia
Prospective study of immunogenicity to SARS-CoV-2 booster vaccines in multiple myeloma and Waldenström macroglobulinemia
Long-term follow-up of venetoclax monotherapy in previously treated patients with Waldenström macroglobulinemia
Insights from the 12th International Workshop on Waldenstrom’s Macroglobulinemia
Ibrutinib plus rituximab versus ibrutinib monotherapy in patients with Waldenström macroglobulinemia: A pooled analysis
Diagnosis and Management of Waldenstrom's Macroglobulinemia
Zanubrutinib for the treatment of Bing–Neel syndrome
Development and characterization of the novel MYD88 mutated, 6q deleted BCWM.2 cell line for Waldenström macroglobulinaemia
Depth of Response From Fixed-Duration Treatment Is Associated With Superior Survival in Waldenstrom Macroglobulinemia